NRP-2945

N/A

Report date: 2024/05/14 17:57:13
NME

Base Information

Drug NameNRP-2945
Drug Alias NameNNZ-4945NRP-2945
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsNeurons stimulants
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsRett SyndromeAmyotrophic Lateral SclerosisAngelman Syndrome +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuren Pharmaceuticals LtdCalzada Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuren Pharmaceuticals LtdCuronz Ltd
Inactive CompaniesN/A
Active IndicationsRett SyndromeAmyotrophic Lateral SclerosisAngelman Syndrome +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A